Official NIH NLM MEDLINE / PubMed Citation • PMID: 42975717
Oncologic efficacy and safety of stereotactic body radiotherapy for oligometastatic non-small cell lung cancer: a systemic meta-analysis
Clinical & experimental metastasis
Verbatim Formal Study Abstract
This meta-analysis indicates that SBRT yields favorable treatment outcomes for patients with oligometastatic NSCLC with manageable toxicities. When anatomically feasible, delivering an ablative dose-100 Gy 10 in biologically effective dose-is recommended.